Pt age: please note that this age is the average age of the patients reported in the article, as the actual age of patients involved was not provided.Pt gender: please note that this is the gender of the majority of patients reported in the article as the actual genders of patients involved was not provided.Date of event: please note that this date is based off the date of publication of the article as the actual event date was not provided.Concomitant medical products: product id neu_ins_stimulator, product type: implantable neurostimulator.(x53).A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Ostrem jl, san luciano m, dodenhoff ka, ziman n, markun lc, racine ca, de hemptinne c, volz mm, heath sl, starr pa.Subthalamic nucleus deep brain stimulation in isolated dystonia: a 3-year follow-up study.Neurology 2017; 88:1-11.Summary: the objective of this study was to report long-term safety and efficacy outcomes of a large cohort of patients with medically refractory isolated dystonia treated with subthalamic nucleus (stn) deep brain stimulation (dbs).Reported events: 1 patient with stn dbs for dystonia experienced surgery-related urinary tract infection within 12 months of implant.This was noted to be resolved; 1 patient with stn dbs for dystonia experienced surgery-related ins movement between 12 and 36 months after implant.This was noted to be ¿ongoing.¿; 1 patient with stn dbs for dystonia experienced a shocking sensation related to the device within 12 months of implant; this was noted to be resolved; 1 patient with subthalamic nucleus (stn) deep brain stimulation (dbs) for dystonia experienced surgery-related implantable neurostimulator (ins) movement within 12 months of implant.This was noted to be ¿ongoing.¿ the following device specifics were provided: lead model 3389; implantable neurostimulator kinetra model 7428; implantable neurostimulator activa pc model 37601.
|